Literature DB >> 25652355

A Japanese case of cerebellar ataxia, spastic paraparesis and deep sensory impairment associated with a novel homozygous TTC19 mutation.

Misako Kunii1, Hiroshi Doi1, Yuichi Higashiyama1, Chiharu Kugimoto1, Naohisa Ueda1, Junichi Hirata1, Atsuko Tomita-Katsumoto1, Mari Kashikura-Kojima1, Shun Kubota1, Midori Taniguchi2, Kei Murayama2, Mitsuko Nakashima3, Yoshinori Tsurusaki3, Noriko Miyake3, Hirotomo Saitsu3, Naomichi Matsumoto3, Fumiaki Tanaka1.   

Abstract

Mitochondrial complex III (CIII) deficiency comprises a group of complex and heterogeneous genetic disorders. TTC19 mutations constitute a rare cause of CIII deficiency and are associated with neurological disorders in childhood and adulthood. Herein, we describe a 27-year-old Japanese man with cerebellar ataxia, spastic paraparesis, loss of deep sensation, mild frontal lobe dysfunction and transient psychiatric symptoms. Brain magnetic resonance imaging showed cerebellar atrophy and bilateral high-intensity signals in the inferior olives and regions adjacent to periaqueductal gray matter, on T2-weighted images. On whole-exome sequencing, we detected a novel homozygous frameshift mutation c.157_158dup [p.Pro54Alafs*48] in TTC19. Mitochondrial enzyme assays confirmed mild impairment of CIII enzymatic activity in lymphoblasts, which was consistent with TTC19-related CIII deficiency. His symptoms and radiological findings demonstrated an early stage or mild form of this disease, and further clarify the characteristics of patients with rare TTC19 mutations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25652355     DOI: 10.1038/jhg.2015.7

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  27 in total

1.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

2.  Novel TTC19 mutation in a family with severe psychiatric manifestations and complex III deficiency.

Authors:  Célia Nogueira; José Barros; Maria José Sá; Luísa Azevedo; Ricardo Taipa; Alessandra Torraco; Maria Chiara Meschini; Daniela Verrigni; Claudia Nesti; Teresa Rizza; João Teixeira; Rosalba Carrozzo; Manuel Melo Pires; Laura Vilarinho; Filippo M Santorelli
Journal:  Neurogenetics       Date:  2013-03-28       Impact factor: 2.660

3.  Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases.

Authors:  Masaaki Waragai; Tatsuo Yamada; Hiroshi Matsuda
Journal:  J Neurol Sci       Date:  2007-05-09       Impact factor: 3.181

4.  Mitochondrial complex III deficiency caused by a homozygous UQCRC2 mutation presenting with neonatal-onset recurrent metabolic decompensation.

Authors:  Noriko Miyake; Shoji Yano; Chika Sakai; Hideyuki Hatakeyama; Yuichi Matsushima; Masaaki Shiina; Yoriko Watanabe; James Bartley; Jose E Abdenur; Raymond Y Wang; Richard Chang; Yoshinori Tsurusaki; Hiroshi Doi; Mitsuko Nakashima; Hirotomo Saitsu; Kazuhiro Ogata; Yu-Ichi Goto; Naomichi Matsumoto
Journal:  Hum Mutat       Date:  2013-01-29       Impact factor: 4.878

5.  Mitochondrial complex III deficiency associated with a homozygous mutation in UQCRQ.

Authors:  Ortal Barel; Zamir Shorer; Hagit Flusser; Rivka Ofir; Ginat Narkis; Gal Finer; Hanah Shalev; Ahmad Nasasra; Ann Saada; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2008-04-24       Impact factor: 11.025

6.  Mutations in CYC1, encoding cytochrome c1 subunit of respiratory chain complex III, cause insulin-responsive hyperglycemia.

Authors:  Pauline Gaignard; Minal Menezes; Manuel Schiff; Aurélien Bayot; Malgorzata Rak; Hélène Ogier de Baulny; Chen-Hsien Su; Mylene Gilleron; Anne Lombes; Heni Abida; Alexander Tzagoloff; Lisa Riley; Sandra T Cooper; Kym Mina; Padma Sivadorai; Mark R Davis; Richard J N Allcock; Nina Kresoje; Nigel G Laing; David R Thorburn; Abdelhamid Slama; John Christodoulou; Pierre Rustin
Journal:  Am J Hum Genet       Date:  2013-08-01       Impact factor: 11.025

7.  Leigh syndrome: clinical features and biochemical and DNA abnormalities.

Authors:  S Rahman; R B Blok; H H Dahl; D M Danks; D M Kirby; C W Chow; J Christodoulou; D R Thorburn
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

8.  Impaired complex III assembly associated with BCS1L gene mutations in isolated mitochondrial encephalopathy.

Authors:  Erika Fernandez-Vizarra; Marianna Bugiani; Paola Goffrini; Franco Carrara; Laura Farina; Elena Procopio; Alice Donati; Graziella Uziel; Iliana Ferrero; Massimo Zeviani
Journal:  Hum Mol Genet       Date:  2007-04-02       Impact factor: 6.150

9.  Exome sequencing reveals a novel TTC19 mutation in an autosomal recessive spinocerebellar ataxia patient.

Authors:  Hiroyuki Morino; Ryosuke Miyamoto; Shizuo Ohnishi; Hirofumi Maruyama; Hideshi Kawakami
Journal:  BMC Neurol       Date:  2014-01-07       Impact factor: 2.474

10.  Mutations in the UQCC1-interacting protein, UQCC2, cause human complex III deficiency associated with perturbed cytochrome b protein expression.

Authors:  Elena J Tucker; Bas F J Wanschers; Radek Szklarczyk; Hayley S Mountford; Xiaonan W Wijeyeratne; Mariël A M van den Brand; Anne M Leenders; Richard J Rodenburg; Boris Reljić; Alison G Compton; Ann E Frazier; Damien L Bruno; John Christodoulou; Hitoshi Endo; Michael T Ryan; Leo G Nijtmans; Martijn A Huynen; David R Thorburn
Journal:  PLoS Genet       Date:  2013-12-26       Impact factor: 5.917

View more
  7 in total

1.  Parkinsonism, Olivary Hypertrophy and Cerebellar Atrophy with TTC19 Gene Mutation.

Authors:  Rohan R Mahale; Gautham Arunachal; Jyothi Gautam; Debayan Dutta; Jennifer Kovoor; Pooja Mailankody; Hansashree Padmanabha; P S Mathuranath
Journal:  Ann Indian Acad Neurol       Date:  2021-04-16       Impact factor: 1.383

2.  Mutations in TTC19: expanding the molecular, clinical and biochemical phenotype.

Authors:  Johannes Koch; Peter Freisinger; René G Feichtinger; Franz A Zimmermann; Christian Rauscher; Hans P Wagentristl; Vassiliki Konstantopoulou; Rainer Seidl; Tobias B Haack; Holger Prokisch; Uwe Ahting; Wolfgang Sperl; Johannes A Mayr; Esther M Maier
Journal:  Orphanet J Rare Dis       Date:  2015-04-02       Impact factor: 4.123

3.  Exploiting pyocyanin to treat mitochondrial disease due to respiratory complex III dysfunction.

Authors:  Roberta Peruzzo; Samantha Corrà; Roberto Costa; Michele Brischigliaro; Tatiana Varanita; Lucia Biasutto; Chiara Rampazzo; Daniele Ghezzi; Luigi Leanza; Mario Zoratti; Massimo Zeviani; Cristiano De Pittà; Carlo Viscomi; Rodolfo Costa; Ildikò Szabò
Journal:  Nat Commun       Date:  2021-04-08       Impact factor: 17.694

Review 4.  Organization of the Respiratory Supercomplexes in Cells with Defective Complex III: Structural Features and Metabolic Consequences.

Authors:  Michela Rugolo; Claudia Zanna; Anna Maria Ghelli
Journal:  Life (Basel)       Date:  2021-04-17

Review 5.  Mitochondrial Neurodegeneration.

Authors:  Massimo Zeviani; Carlo Viscomi
Journal:  Cells       Date:  2022-02-11       Impact factor: 6.600

Review 6.  Mitochondrial protein dysfunction in pathogenesis of neurological diseases.

Authors:  Liang Wang; Ziyun Yang; Xiumei He; Shiming Pu; Cheng Yang; Qiong Wu; Zuping Zhou; Xiaobo Cen; Hongxia Zhao
Journal:  Front Mol Neurosci       Date:  2022-09-07       Impact factor: 6.261

Review 7.  Nuclear gene mutations as the cause of mitochondrial complex III deficiency.

Authors:  Erika Fernández-Vizarra; Massimo Zeviani
Journal:  Front Genet       Date:  2015-04-09       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.